LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 18

Search options

  1. Article: Bcl-2 family members regulate anoxia-induced cell death.

    Shroff, Emelyn H / Snyder, Colleen / Chandel, Navdeep S

    Antioxidants & redox signaling

    2007  Volume 9, Issue 9, Page(s) 1405–1409

    Abstract: The mechanisms underlying anoxia (0-0.5% oxygen)-induced cell death are not fully understood. Here we discuss the mechanisms by which cells undergo apoptosis in the absence of oxygen. Cell death during anoxia occurs via the intrinsic pathway of apoptosis. ...

    Abstract The mechanisms underlying anoxia (0-0.5% oxygen)-induced cell death are not fully understood. Here we discuss the mechanisms by which cells undergo apoptosis in the absence of oxygen. Cell death during anoxia occurs via the intrinsic pathway of apoptosis. Key regulators of apoptosis during anoxia are the Bcl-2 family of proteins. The pathway is initiated by the loss of function of the prosurvival Bcl-2 family members Mcl-1 and Bcl-2/Bcl-XL, resulting in Bax- or Bak-dependent release of cytochrome c and subsequent caspase-9-dependent cell death.
    MeSH term(s) Apoptosis ; Cell Death ; Homeostasis ; Hypoxia/pathology ; Hypoxia/physiopathology ; Models, Biological ; Proto-Oncogene Proteins c-bcl-2/physiology
    Chemical Substances Proto-Oncogene Proteins c-bcl-2
    Language English
    Publishing date 2007-09
    Publishing country United States
    Document type Journal Article ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't ; Review
    ZDB-ID 1483836-9
    ISSN 1557-7716 ; 1523-0864
    ISSN (online) 1557-7716
    ISSN 1523-0864
    DOI 10.1089/ars.2007.1731
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Role of Bcl-2 family members in anoxia induced cell death.

    Shroff, Emelyn H / Snyder, Colleen / Chandel, Navdeep S

    Cell cycle (Georgetown, Tex.)

    2007  Volume 6, Issue 7, Page(s) 807–809

    Abstract: Anoxia, the condition of oxygen deprivation, induces apoptosis via the intrinsic apoptotic pathway. Cells deficient in both Bax and Bak do not undergo cell death during anoxia. However, the underlying mechanism of anoxia induced cell death is not well ... ...

    Abstract Anoxia, the condition of oxygen deprivation, induces apoptosis via the intrinsic apoptotic pathway. Cells deficient in both Bax and Bak do not undergo cell death during anoxia. However, the underlying mechanism of anoxia induced cell death is not well defined. Here we report our latest findings of two critical events that are required to induce cell death during anoxia. First, a key member of the Bcl-2 family of pro-survival proteins, Mcl-1, undergoes proteasomal-dependent degradation. The loss of Mcl-1 protein is independent of Bax or Bak indicating this is an early event in the apoptotic cascade. Second, cells inhibit the mitochondrial electron transport chain to negate the pro-survival function of Bcl-2/Bcl-X(L). These observations indicate that loss of pro-survival function is necessary for anoxia induced cell death.
    MeSH term(s) Animals ; Apoptosis/physiology ; Apoptosis Regulatory Proteins/metabolism ; Cell Hypoxia/physiology ; Cell Survival/physiology ; Electron Transport/physiology ; Humans ; Myeloid Cell Leukemia Sequence 1 Protein ; Neoplasm Proteins/metabolism ; Proteasome Endopeptidase Complex/metabolism ; Proto-Oncogene Proteins c-bcl-2/metabolism ; Signal Transduction/physiology
    Chemical Substances Apoptosis Regulatory Proteins ; Myeloid Cell Leukemia Sequence 1 Protein ; Neoplasm Proteins ; Proto-Oncogene Proteins c-bcl-2 ; Proteasome Endopeptidase Complex (EC 3.4.25.1)
    Language English
    Publishing date 2007-04-22
    Publishing country United States
    Document type Journal Article ; Research Support, N.I.H., Extramural ; Review
    ZDB-ID 2146183-1
    ISSN 1551-4005 ; 1538-4101 ; 1554-8627
    ISSN (online) 1551-4005
    ISSN 1538-4101 ; 1554-8627
    DOI 10.4161/cc.6.7.4044
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Nitric oxide induces cell death by regulating anti-apoptotic BCL-2 family members.

    Snyder, Colleen M / Shroff, Emelyn H / Liu, Jing / Chandel, Navdeep S

    PloS one

    2009  Volume 4, Issue 9, Page(s) e7059

    Abstract: Nitric oxide (NO) activates the intrinsic apoptotic pathway to induce cell death. However, the mechanism by which this pathway is activated in cells exposed to NO is not known. Here we report that BAX and BAK are activated by NO and that cytochrome c is ... ...

    Abstract Nitric oxide (NO) activates the intrinsic apoptotic pathway to induce cell death. However, the mechanism by which this pathway is activated in cells exposed to NO is not known. Here we report that BAX and BAK are activated by NO and that cytochrome c is released from the mitochondria. Cells deficient in Bax and Bak or Caspase-9 are completely protected from NO-induced cell death. The individual loss of the BH3-only proteins, Bim, Bid, Puma, Bad or Noxa, or Bid knockdown in Bim(-/-)/Puma(-/-) MEFs, does not prevent NO-induced cell death. Our data show that the anti-apoptotic protein MCL-1 undergoes ASK1-JNK1 mediated degradation upon exposure to NO, and that cells deficient in either Ask1 or Jnk1 are protected against NO-induced cell death. NO can inhibit the mitochondrial electron transport chain resulting in an increase in superoxide generation and peroxynitrite formation. However, scavengers of ROS or peroxynitrite do not prevent NO-induced cell death. Collectively, these data indicate that NO degrades MCL-1 through the ASK1-JNK1 axis to induce BAX/BAK-dependent cell death.
    MeSH term(s) Animals ; Apoptosis ; Caspase 9/metabolism ; Cytochromes c/metabolism ; Electron Transport Chain Complex Proteins/metabolism ; Fibroblasts/metabolism ; Gene Expression Regulation ; MAP Kinase Kinase Kinase 5/metabolism ; Mice ; Mitogen-Activated Protein Kinase 8/metabolism ; Multigene Family ; Myeloid Cell Leukemia Sequence 1 Protein ; Nitric Oxide/metabolism ; Proto-Oncogene Proteins c-bcl-2/metabolism ; Reactive Oxygen Species ; bcl-2 Homologous Antagonist-Killer Protein/metabolism ; bcl-2-Associated X Protein/metabolism
    Chemical Substances Bak1 protein, mouse ; Bax protein, mouse ; Electron Transport Chain Complex Proteins ; Mcl1 protein, mouse ; Myeloid Cell Leukemia Sequence 1 Protein ; Proto-Oncogene Proteins c-bcl-2 ; Reactive Oxygen Species ; bcl-2 Homologous Antagonist-Killer Protein ; bcl-2-Associated X Protein ; Nitric Oxide (31C4KY9ESH) ; Cytochromes c (9007-43-6) ; Mitogen-Activated Protein Kinase 8 (EC 2.7.11.24) ; MAP Kinase Kinase Kinase 5 (EC 2.7.11.25) ; Map3k5 protein, mouse (EC 2.7.11.25) ; Caspase 9 (EC 3.4.22.-)
    Language English
    Publishing date 2009-09-21
    Publishing country United States
    Document type Journal Article ; Research Support, N.I.H., Extramural
    ISSN 1932-6203
    ISSN (online) 1932-6203
    DOI 10.1371/journal.pone.0007059
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Characterization of MYC-induced tumorigenesis by in situ lipid profiling.

    Perry, Richard H / Bellovin, David I / Shroff, Emelyn H / Ismail, Ali I / Zabuawala, Tahera / Felsher, Dean W / Zare, Richard N

    Analytical chemistry

    2013  Volume 85, Issue 9, Page(s) 4259–4262

    Abstract: We apply desorption electrospray ionization mass spectrometry imaging (DESI-MSI) to provide an in situ lipidomic profile of genetically modified tissues from a conditional transgenic mouse model of MYC-induced hepatocellular carcinoma (HCC). This unique, ...

    Abstract We apply desorption electrospray ionization mass spectrometry imaging (DESI-MSI) to provide an in situ lipidomic profile of genetically modified tissues from a conditional transgenic mouse model of MYC-induced hepatocellular carcinoma (HCC). This unique, label-free approach of combining DESI-MSI with the ability to turn specific genes on and off has led to the discovery of highly specific lipid molecules associated with MYC-induced tumor onset. We are able to distinguish normal from MYC-induced malignant cells. Our approach provides a strategy to define a precise molecular picture at a resolution of about 200 μm that may be useful in identifying lipid molecules that define how the MYC oncogene initiates and maintains tumorigenesis.
    MeSH term(s) Animals ; Carcinogenesis/genetics ; Carcinogenesis/metabolism ; Carcinoma, Hepatocellular/genetics ; Carcinoma, Hepatocellular/metabolism ; Carcinoma, Hepatocellular/pathology ; Disease Models, Animal ; Lipid Metabolism/genetics ; Lipids/genetics ; Liver Neoplasms/genetics ; Liver Neoplasms/metabolism ; Liver Neoplasms/pathology ; Mice ; Mice, Transgenic ; Proto-Oncogene Proteins c-myc/genetics ; Proto-Oncogene Proteins c-myc/metabolism ; Spectrometry, Mass, Electrospray Ionization
    Chemical Substances Lipids ; Proto-Oncogene Proteins c-myc
    Language English
    Publishing date 2013-04-18
    Publishing country United States
    Document type Letter ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't ; Research Support, U.S. Gov't, Non-P.H.S.
    ZDB-ID 1508-8
    ISSN 1520-6882 ; 0003-2700
    ISSN (online) 1520-6882
    ISSN 0003-2700
    DOI 10.1021/ac400479j
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: Who Needs Big Health Sector Reforms Anyway? Seychelles' Road to UHC Provides Lessons for Sub-Saharan Africa and Island Nations.

    Workie, Netsanet Walelign / Shroff, Emelyn / S Yazbeck, Abdo / Nguyen, Son Nam / Karamagi, Humphrey

    Health systems and reform

    2018  Volume 4, Issue 4, Page(s) 362–371

    Abstract: The road to universal health coverage (UHC) needs not be driven by big reforms that include the initiation of health insurance, provider-funder separation, results-based financing, or other large health sector reforms advocated in many countries in sub- ... ...

    Abstract The road to universal health coverage (UHC) needs not be driven by big reforms that include the initiation of health insurance, provider-funder separation, results-based financing, or other large health sector reforms advocated in many countries in sub-Saharan Africa and elsewhere. The Seychelles experience, documented through a series of analytical products like public expenditure reviews and supporting surveys with assistance from the World Bank and World Health Organization (WHO), shows an alternative, more incremental reform road to UHC, with important lessons to the region and other small-population or island nations. Done well, in some countries, a basic supply-side funded, publicly owned and operated, and integrated health system can produce excellent health outcomes in a cost-effective and sustainable way. The article traces some of the factors that facilitated this success in the Seychelles, including high political commitment, strong voice and a downward accountability culture, strong public health functions, and an impressive investment in primary health care. These factors help explain past successes and also provide a good basis for adaptation of health systems to dramatic shifts in the epidemiological and demographic transitions, disease outbreaks, and rising public expectation and demand for high quality of care. Once again, how the Seychelles responds can show the way for other countries in the region and elsewhere regardless of the types of reforms countries engage in.
    Language English
    Publishing date 2018-11-06
    Publishing country United States
    Document type Journal Article
    ZDB-ID 2820935-7
    ISSN 2328-8620 ; 2328-8620
    ISSN (online) 2328-8620
    ISSN 2328-8620
    DOI 10.1080/23288604.2018.1513265
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Nitric oxide induces cell death by regulating anti-apoptotic BCL-2 family members.

    Colleen M Snyder / Emelyn H Shroff / Jing Liu / Navdeep S Chandel

    PLoS ONE, Vol 4, Iss 9, p e

    2009  Volume 7059

    Abstract: Nitric oxide (NO) activates the intrinsic apoptotic pathway to induce cell death. However, the mechanism by which this pathway is activated in cells exposed to NO is not known. Here we report that BAX and BAK are activated by NO and that cytochrome c is ... ...

    Abstract Nitric oxide (NO) activates the intrinsic apoptotic pathway to induce cell death. However, the mechanism by which this pathway is activated in cells exposed to NO is not known. Here we report that BAX and BAK are activated by NO and that cytochrome c is released from the mitochondria. Cells deficient in Bax and Bak or Caspase-9 are completely protected from NO-induced cell death. The individual loss of the BH3-only proteins, Bim, Bid, Puma, Bad or Noxa, or Bid knockdown in Bim(-/-)/Puma(-/-) MEFs, does not prevent NO-induced cell death. Our data show that the anti-apoptotic protein MCL-1 undergoes ASK1-JNK1 mediated degradation upon exposure to NO, and that cells deficient in either Ask1 or Jnk1 are protected against NO-induced cell death. NO can inhibit the mitochondrial electron transport chain resulting in an increase in superoxide generation and peroxynitrite formation. However, scavengers of ROS or peroxynitrite do not prevent NO-induced cell death. Collectively, these data indicate that NO degrades MCL-1 through the ASK1-JNK1 axis to induce BAX/BAK-dependent cell death.
    Keywords Medicine ; R ; Science ; Q
    Subject code 570
    Language English
    Publishing date 2009-09-01T00:00:00Z
    Publisher Public Library of Science (PLoS)
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  7. Article: Characterization of MYC-Induced Tumorigenesis by in Situ Lipid Profiling

    Perry, Richard H / Bellovin David I / Felsher Dean W / Ismail Ali I / Shroff Emelyn H / Zabuawala Tahera / Zare Richard N

    Analytical chemistry. 2013 May 07, v. 85, no. 9

    2013  

    Abstract: We apply desorption electrospray ionization mass spectrometry imaging (DESI-MSI) to provide an in situ lipidomic profile of genetically modified tissues from a conditional transgenic mouse model of MYC-induced hepatocellular carcinoma (HCC). This unique, ...

    Abstract We apply desorption electrospray ionization mass spectrometry imaging (DESI-MSI) to provide an in situ lipidomic profile of genetically modified tissues from a conditional transgenic mouse model of MYC-induced hepatocellular carcinoma (HCC). This unique, label-free approach of combining DESI-MSI with the ability to turn specific genes on and off has led to the discovery of highly specific lipid molecules associated with MYC-induced tumor onset. We are able to distinguish normal from MYC-induced malignant cells. Our approach provides a strategy to define a precise molecular picture at a resolution of about 200 μm that may be useful in identifying lipid molecules that define how the MYC oncogene initiates and maintains tumorigenesis.
    Keywords animal models ; carcinogenesis ; desorption ; electrospray ionization mass spectrometry ; hepatoma ; image analysis ; lipid composition ; lipids ; oncogenes ; tissues ; transgenic animals
    Language English
    Dates of publication 2013-0507
    Size p. 4259-4262.
    Publishing place American Chemical Society
    Document type Article
    ZDB-ID 1508-8
    ISSN 1520-6882 ; 0003-2700
    ISSN (online) 1520-6882
    ISSN 0003-2700
    DOI 10.1021/ac400479j
    Database NAL-Catalogue (AGRICOLA)

    More links

    Kategorien

  8. Article ; Online: MYC oncogene overexpression drives renal cell carcinoma in a mouse model through glutamine metabolism.

    Shroff, Emelyn H / Eberlin, Livia S / Dang, Vanessa M / Gouw, Arvin M / Gabay, Meital / Adam, Stacey J / Bellovin, David I / Tran, Phuoc T / Philbrick, William M / Garcia-Ocana, Adolfo / Casey, Stephanie C / Li, Yulin / Dang, Chi V / Zare, Richard N / Felsher, Dean W

    Proceedings of the National Academy of Sciences of the United States of America

    2015  Volume 112, Issue 21, Page(s) 6539–6544

    Abstract: The MYC oncogene is frequently mutated and overexpressed in human renal cell carcinoma (RCC). However, there have been no studies on the causative role of MYC or any other oncogene in the initiation or maintenance of kidney tumorigenesis. Here, we show ... ...

    Abstract The MYC oncogene is frequently mutated and overexpressed in human renal cell carcinoma (RCC). However, there have been no studies on the causative role of MYC or any other oncogene in the initiation or maintenance of kidney tumorigenesis. Here, we show through a conditional transgenic mouse model that the MYC oncogene, but not the RAS oncogene, initiates and maintains RCC. Desorption electrospray ionization-mass-spectrometric imaging was used to obtain chemical maps of metabolites and lipids in the mouse RCC samples. Gene expression analysis revealed that the mouse tumors mimicked human RCC. The data suggested that MYC-induced RCC up-regulated the glutaminolytic pathway instead of the glycolytic pathway. The pharmacologic inhibition of glutamine metabolism with bis-2-(5-phenylacetamido-1,2,4-thiadiazol-2-yl)ethyl sulfide impeded MYC-mediated RCC tumor progression. Our studies demonstrate that MYC overexpression causes RCC and points to the inhibition of glutamine metabolism as a potential therapeutic approach for the treatment of this disease.
    MeSH term(s) Animals ; Carcinoma, Renal Cell/genetics ; Carcinoma, Renal Cell/metabolism ; Carcinoma, Renal Cell/pathology ; Cell Line, Tumor ; Disease Models, Animal ; Disease Progression ; Enzyme Inhibitors/pharmacology ; Genes, myc ; Genes, ras ; Glutaminase/antagonists & inhibitors ; Glutaminase/metabolism ; Glutamine/metabolism ; Humans ; Kidney Neoplasms/genetics ; Kidney Neoplasms/metabolism ; Kidney Neoplasms/pathology ; Lipid Metabolism ; Mice ; Mice, SCID ; Mice, Transgenic ; RNA, Messenger/genetics ; RNA, Messenger/metabolism ; RNA, Neoplasm/genetics ; RNA, Neoplasm/metabolism ; Spectrometry, Mass, Electrospray Ionization ; Sulfides/pharmacology ; Thiadiazoles/pharmacology ; Up-Regulation
    Chemical Substances Enzyme Inhibitors ; RNA, Messenger ; RNA, Neoplasm ; Sulfides ; Thiadiazoles ; bis-2-(5-phenylacetamido-1,2,4-thiadiazol-2-yl)ethyl sulfide ; Glutamine (0RH81L854J) ; Glutaminase (EC 3.5.1.2)
    Language English
    Publishing date 2015-05-11
    Publishing country United States
    Document type Journal Article ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't
    ZDB-ID 209104-5
    ISSN 1091-6490 ; 0027-8424
    ISSN (online) 1091-6490
    ISSN 0027-8424
    DOI 10.1073/pnas.1507228112
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: BH3 peptides induce mitochondrial fission and cell death independent of BAX/BAK.

    Shroff, Emelyn H / Snyder, Colleen M / Budinger, G R Scott / Jain, Manu / Chew, Teng-Leong / Khuon, Satya / Perlman, Harris / Chandel, Navdeep S

    PloS one

    2009  Volume 4, Issue 5, Page(s) e5646

    Abstract: BH3 only proteins trigger cell death by interacting with pro- and anti-apoptotic members of the BCL-2 family of proteins. Here we report that BH3 peptides corresponding to the death domain of BH3-only proteins, which bind all the pro-survival BCL-2 ... ...

    Abstract BH3 only proteins trigger cell death by interacting with pro- and anti-apoptotic members of the BCL-2 family of proteins. Here we report that BH3 peptides corresponding to the death domain of BH3-only proteins, which bind all the pro-survival BCL-2 family proteins, induce cell death in the absence of BAX and BAK. The BH3 peptides did not cause the release of cytochrome c from isolated mitochondria or from mitochondria in cells. However, the BH3 peptides did cause a decrease in mitochondrial membrane potential but did not induce the opening of the mitochondrial permeability transition pore. Interestingly, the BH3 peptides induced mitochondria to undergo fission in the absence of BAX and BAK. The binding of BCL-X(L) with dynamin-related protein 1 (DRP1), a GTPase known to regulate mitochondrial fission, increased in the presence of BH3 peptides. These results suggest that pro-survival BCL-2 proteins regulate mitochondrial fission and cell death in the absence of BAX and BAK.
    MeSH term(s) Animals ; Caspase Inhibitors ; Cell Death/drug effects ; Cytochromes c/metabolism ; Embryo, Mammalian/cytology ; Fibroblasts/cytology ; Fibroblasts/drug effects ; Fibroblasts/enzymology ; Fibroblasts/ultrastructure ; Membrane Potential, Mitochondrial/drug effects ; Mice ; Microinjections ; Microtubule-Associated Proteins/metabolism ; Mitochondria/drug effects ; Mitochondria/enzymology ; Mitochondria/metabolism ; Mitochondria/ultrastructure ; Mitochondrial Membrane Transport Proteins/metabolism ; Mitochondrial Permeability Transition Pore ; Peptides/pharmacology ; Protease Inhibitors/pharmacology ; Protein Binding/drug effects ; bcl-2-Associated X Protein/deficiency ; bcl-2-Associated X Protein/metabolism ; bcl-X Protein/deficiency ; bcl-X Protein/metabolism
    Chemical Substances Caspase Inhibitors ; Microtubule-Associated Proteins ; Mitochondrial Membrane Transport Proteins ; Mitochondrial Permeability Transition Pore ; Peptides ; Protease Inhibitors ; bcl-2-Associated X Protein ; bcl-X Protein ; Cytochromes c (9007-43-6)
    Language English
    Publishing date 2009-05-21
    Publishing country United States
    Document type Journal Article ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't
    ISSN 1932-6203
    ISSN (online) 1932-6203
    DOI 10.1371/journal.pone.0005646
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: High throughput automated chromatin immunoprecipitation as a platform for drug screening and antibody validation.

    Wu, Angela R / Kawahara, Tiara L A / Rapicavoli, Nicole A / van Riggelen, Jan / Shroff, Emelyn H / Xu, Liwen / Felsher, Dean W / Chang, Howard Y / Quake, Stephen R

    Lab on a chip

    2012  Volume 12, Issue 12, Page(s) 2190–2198

    Abstract: Chromatin immunoprecipitation (ChIP) is an assay for interrogating protein-DNA interactions that is increasingly being used for drug target discovery and screening applications. Currently the complexity of the protocol and the amount of hands-on time ... ...

    Abstract Chromatin immunoprecipitation (ChIP) is an assay for interrogating protein-DNA interactions that is increasingly being used for drug target discovery and screening applications. Currently the complexity of the protocol and the amount of hands-on time required for this assay limits its use to low throughput applications; furthermore, variability in antibody quality poses an additional obstacle in scaling up ChIP for large scale screening purposes. To address these challenges, we report HTChIP, an automated microfluidic-based platform for performing high-throughput ChIP screening measurements of 16 different targets simultaneously, with potential for further scale-up. From chromatin to analyzable PCR results only takes one day using HTChIP, as compared to several days up to one week for conventional protocols. HTChIP can also be used to test multiple antibodies and select the best performer for downstream ChIP applications, saving time and reagent costs of unsuccessful ChIP assays as a result of poor antibody quality. We performed a series of characterization assays to demonstrate that HTChIP can rapidly and accurately evaluate the epigenetic states of a cell, and that it is sensitive enough to detect the changes in the epigenetic state induced by a cytokine stimulant over a fine temporal resolution. With these results, we believe that HTChIP can introduce large improvements in routine ChIP, antibody screening, and drug screening efficiency, and further facilitate the use of ChIP as a valuable tool for research and discovery.
    MeSH term(s) Antibodies/immunology ; Automation ; Cell Proliferation/drug effects ; Chromatin Immunoprecipitation ; Drug Evaluation, Preclinical ; HeLa Cells ; High-Throughput Screening Assays ; Histones/metabolism ; Humans ; Microfluidic Analytical Techniques ; Tumor Necrosis Factor-alpha/metabolism ; Tumor Necrosis Factor-alpha/pharmacology
    Chemical Substances Antibodies ; Histones ; Tumor Necrosis Factor-alpha
    Language English
    Publishing date 2012-05-08
    Publishing country England
    Document type Journal Article ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't ; Research Support, U.S. Gov't, Non-P.H.S.
    ZDB-ID 2056646-3
    ISSN 1473-0189 ; 1473-0197
    ISSN (online) 1473-0189
    ISSN 1473-0197
    DOI 10.1039/c2lc21290k
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top